Sari H. Enschede
- Molecular Biology top 5%
- Genetics top 0.5%
- Pathology and Forensic Medicine top 0.5%
- Oncology top 2%
- Hematology top 1%
- Co-authors
- Rod HumerickhouseAndrew W. RobertsJohn F. SeymourWilliam G. WierdaJohn F. GerecitanoThomas J. KippsJennifer R. BrownTodd Busman
- Topics
- Chronic Lymphocytic Leukemia Research (36 papers)Lymphoma Diagnosis and Treatment (18 papers)Multiple Myeloma Research and Treatments (9 papers)
- Partner nations
- United StatesAustraliaFrance
In The Last Decade
Sari H. Enschede
46 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Molecular Biology 2.1k
- Genetics 1.7k
- Pathology and Forensic Medicine 1.3k
- Oncology 1.2k
- Hematology 1.0k
Countries citing papers authored by Sari H. Enschede
This map shows the geographic impact of Sari H. Enschede's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sari H. Enschede with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sari H. Enschede more than expected).
Fields of papers citing papers by Sari H. Enschede
This network shows the impact of papers produced by Sari H. Enschede. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sari H. Enschede. The network helps show where Sari H. Enschede may publish in the future.
Co-authorship network of co-authors of Sari H. Enschede
This figure shows the co-authorship network connecting the top 25 collaborators of Sari H. Enschede. A scholar is included among the top collaborators of Sari H. Enschede based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sari H. Enschede. Sari H. Enschede is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 51 | |
| 2 | 4 | |
| 3 | 49 | |
| 4 | Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemiabreakdown → | 1337 |
| 5 | 3 | |
| 6 | 6 | |
| 7 | 79 | |
| 8 | 13 | |
| 9 | 13 | |
| 10 | 20 | |
| 11 | 18 | |
| 12 | 6 | |
| 13 | 28 | |
| 14 | 462 | |
| 15 | Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Diseasebreakdown → | 632 |
| 16 | Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activitybreakdown → | 663 |
| 17 | 15 | |
| 18 | 23 | |
| 19 | 18 | |
| 20 | 2 |
About Sari H. Enschede
Sari H. Enschede is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 46 papers that have together received 4.0k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (36 papers), Lymphoma Diagnosis and Treatment (18 papers) and Multiple Myeloma Research and Treatments (9 papers). The work is most often cited by research in Genetics (1.7k citations), Hematology (1.0k citations) and Pathology and Forensic Medicine (1.3k citations). Sari H. Enschede has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Rod Humerickhouse, Andrew W. Roberts, John F. Seymour, William G. Wierda, John F. Gerecitano, Thomas J. Kipps, Jennifer R. Brown, Todd Busman, Andrew Krivoshik and Hao Xiong. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.